[Hormone treatment of sex disorders in menopause--causal therapy or placebo?].
Clinical reports on successful hormonal treatment of climacteric or menopausal sexual dysfunctions are in contradiction with the lack of oestrous phenomena in humans as well as with the results of double-blind studies finding no objective proof for the alleged hormonal influence. A review of recent studies on the topic showed, that apart from a critical threshold, hormones exert no influence on sexual behaviour that would go beyond the alleviation of vasomotoric or genital menopausal symptoms or their consequences. However, psychosocial and relational factors play a major role in sexual dysfunctions generally and at this age of the "empty nest" and a doctor-patient relationship based on trust may well help in coping with them. Finally, a (new?) understanding of genital sexuality as a concise body-language or literally an incarnation of the relationship is advocated and may add a new dimension and quality to a couple's sex life.
Loewit
K
K
Institut für Medizinische Biologie und Humangenetik, Universität Innsbruck.
D000328:Adult; D002979:Climacteric / Q000187:drug effects* / Q000523:psychology; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D007989:Libido / Q000187:drug effects*; D008875:Middle Aged; D045167:Progesterone Congeners / Q000627:therapeutic use; D012725:Sexual Behavior / Q000187:drug effects*; D020018:Sexual Dysfunctions, Psychological / Q000188:drug therapy* / Q000523:psychology; D045165:Testosterone Congeners / Q000627:therapeutic use*
D045167:Progesterone Congeners; D045165:Testosterone Congeners
Hormonbehandlung bei sexuellen Störungen in der Menopause--kausale Therapie oder Plazebo?